Merck Launches Online Platform Fertility.com

Merck

Merck Launches Online Platform Fertility.com

PR74235

DARMSTADT, Germany, July 3, 2018 /PRNewswire=KYODO JBN/ --

    Not intended for U.S. based media

    Fertility.com is the gateway to two online portals:

    - Offering the latest scientific information to healthcare professionals in

the advancing field of fertility

    - Supporting women, men and couples who are looking for information about

fertility and/or undergoing fertility treatment

(Photo: https://mma.prnewswire.com/media/713837/Merck_Fertility_com.jpg )

(Photo: https://mma.prnewswire.com/media/713838/Fertility_com.jpg )

    Merck, a leading science and technology company, today announces the launch

of the new online portal fertility.com. Fertility.com is the entrance to access

two unique and bespoke portals:

    Fertility.com/hcp; developed for fertility Healthcare Professionals (HCPs)

Fertility.com/support; created for women, men and couples who are looking for

information about fertility and/or are undergoing fertility treatment

The Healthcare Professional Portal (fertility.com/hcp) offers a wide range of

resources relevant to physicians' daily practice. On the portal, healthcare

professionals can find key medical and scientific content. This includes the

latest news, publications and developments in the field of fertility as well as

expert opinion videos and educational materials. The portal also provides the

opportunity to discover more about Merck's therapeutics, technologies and

services.

    The Patient Support Portal (fertility.com/support) has been created to

provide a profound source of information for women, men and couples who are

trying or have been trying to conceive. The portal is designed to support

patients at every step of their fertility journey, including educational

materials that help them understand fertility and treatment options. They can

also find lifestyle advice to improve their chances for success.

    Fertility.com is designed with convenience and easy navigation in mind,

ensuring that patients and physicians can easily access the information they

need, anytime and everywhere. This new online platform demonstrates Merck's

commitment to continuing to support people trying to conceive, whilst also

offering HCPs a scientific platform with the latest advances in reproductive

medicine.

    All Merck Press Releases are distributed by e-mail at the same time they

become available on the Merck Website. Please go to

http://www.merckgroup.com/subscribe to register online, change your selection

or discontinue this service.

    About Merck

    Merck is a leading science and technology company in healthcare, life

science and performance materials. Almost 53,000 employees work to further

develop technologies that improve and enhance life - from biopharmaceutical

therapies to treat cancer or multiple sclerosis, cutting-edge systems for

scientific research and production, to liquid crystals for smartphones and LCD

televisions. In 2017, Merck generated sales of € 15.3 billion in 66 countries.

    Founded in 1668, Merck is the world's oldest pharmaceutical and chemical

company. The founding family remains the majority owner of the publicly listed

corporate group. Merck holds the global rights to the Merck name and brand. The

only exceptions are the United States and Canada, where the company operates as

EMD Serono, MilliporeSigma and EMD Performance Materials.

(Logo: http://mma.prnewswire.com/media/472778/Merck_Logo.jpg )

    Your Contact: Dr. Raphaela Farrenkopf, +49-6151-72-2274

SOURCE: Merck

本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。

このプレスリリースには、報道機関向けの情報があります。

プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。

プレスリリース受信に関するご案内

SNSでも最新のプレスリリース情報をいち早く配信中